Inventor · disambiguated record
Marina Penney
Also filed as: PENNEY MARINA · PENNEY MARINA S · PENNEY MARINA SIMEONE
8 granted patents·3 pending applications·9 citations·filing 2017–2024
79Inventor score
Top patents by PatentIndex Score
11 records- 0192US11440907B1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·25 claims
- 0288US11059826B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2019·Granted Jul 13, 2021·3 cites·49 claims
- 0386US11572364B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2021·Granted Feb 7, 2023·1 cites·48 claims
- 0484US2025188070A1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 0579US10815225B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 27, 2020·1 cites·50 claims
- 0677US12195453B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·24 claims
- 0776US12384790B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 0873US11110108B2Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Sep 7, 2021·1 cites·37 claims
- 0962US11980633B2Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitorsVERTEX PHARMA·Filed 2021·Granted May 14, 2024·0 cites·20 claims
- 1046US2021196751A1Methods of cancer treatment using an atr inhibitorVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1145US2024012010A1Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aatVERTEX PHARMA·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →